Bertin I, Colombo G, Gamba P G, Pasquali C, Furlanut M
Riv Neurol. 1986 Sep-Oct;56(5):276-85.
To assess the therapeutic efficacy and tolerability of Clotiazepam in the treatment of anxiety, the drug was administered to 20 subjects suffering from anxiety (12 cases) or from nervous depression (8 cases), all of whom were without psychopharmacological drugs for at least one month prior to the trial. Treatment with Clotiazepam improved the anxiety and brought about a statistically significant reduction in both groups of patients regards the total score in the Hamilton Scale and in the two sub-scale scores (somatic and psychological symptoms). Tolerability to the drug was very satisfactory.
为评估氯噻西泮治疗焦虑症的疗效和耐受性,对20名患有焦虑症(12例)或神经抑郁症(8例)的受试者给药,所有受试者在试验前至少一个月未服用精神药理学药物。氯噻西泮治疗改善了焦虑症状,并且在汉密尔顿量表总分以及两个子量表评分(躯体和心理症状)方面,两组患者均出现了具有统计学意义的降低。该药物的耐受性非常令人满意。